在甲状腺炎和结节患者中随机对 (Anethum Graveolens L.) 进行了安慰剂控制的临床研究
Sabahattin Destek1, İlker Demirbolat2, Ayşegül Yabacı3
1Department of General Surgery, Üsküdar University School of Medicine, Istanbul, Turkey.
Journal of medicinal food
|May 7, 2025
概括
在患有甲状腺炎的患者中,补充剂显著降低了甲状腺结节的大小和炎症. 这种草药使甲状腺刺激激素 (TSH) 水平正常化,表明其作为治疗甲状腺结节的潜力.
科学领域:
- 内分泌学 在内分泌学.
- 草药是一种草药.
- 甲状腺学 甲状腺学
背景情况:
- 甲状腺结节非常普遍,约有50%的人在60岁时受到影响.
- 潜在的原因包括甲状腺功能低下,遗传突变和自身免疫性疾病,这可能导致甲状腺癌.
- (Anethum graveolens L.) 是一种传统的草药,历史上用于治疗甲状腺功能障碍.
研究的目的:
- 为了评估 dill 提取物对被诊断为甲状腺炎和结节的患者的治疗效果.
- 为了评估甲状腺功能标志物,炎症标志物和结体尺寸在 dill 补充剂后的变化.
主要方法:
- 一项随机对照研究涉及68名患有良性甲状腺结节的患者,分为安慰剂 (n=35) 和 dill 提取物 (n=33) 组.
- 参与者每天接受三粒干燥,磨的囊,持续90天.
- 测量的关键参数包括通过超声波测量甲状腺刺激激素 (TSH),自由甲状腺素 (FT4),抗甲状腺过氧化酶 (anti-TPO),C反应蛋白 (CRP) 和甲状腺结节大小.
主要成果:
- 与安慰剂组相比,用 dill 治疗的组表现出 TSH,FT4,抗 TPO 和 CRP 水平的显著降低.
- 超声波检查显示,在接受取物治疗的患者中,甲状腺结节大小显著下降.
- 这些改善,包括正常化的TSH水平,具有统计学意义 (P < .05) 并表明甲状腺炎症的抑制.
结论:
- 甲 (Anethum graveolens L.) 提取物显示出抗炎性质,并有效地减少甲状腺结节的大小.
- 在患有甲状腺结节的患者中,补充甲可以帮助使甲状腺刺激激素水平正常化.
- 推在特定患者群体中补充甲状腺结的治疗.
相关概念视频
Synthesis and Regulation of Thyroid Hormones
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Goiter
Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...


